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Abstract
Appropriate cell sources, bioactive factors and biomaterials for generation of functional and integrated annulus 
fibrosus (AF) tissue analogues are still an unmet need. In the present study, the AF cell markers, collagen 
type I, cluster of differentiation 146 (CD146), mohawk (MKX) and smooth muscle protein 22α (SM22α) were 
found to be suitable indicators of functional AF cell induction. In vitro 2D culture of human AF cells showed 
that transforming growth factor β1 (TGF-β1) upregulated the expression of the functional AF markers and 
increased cell contractility, indicating that TGF-β1-pre-treated AF cells were an appropriate cell source for 
AF tissue regeneration. Furthermore, a tissue engineered construct, composed of polyurethane (PU) scaffold 
with a TGF-β1-supplemented collagen type I hydrogel and human AF cells, was evaluated with in vitro 3D 
culture and ex vivo preclinical bioreactor-loaded organ culture models. The collagen type I hydrogel helped 
maintaining the AF functional phenotype. TGF-β1 supplement within the collagen I hydrogel further promoted 
cell proliferation and matrix production of AF cells within in vitro 3D culture. In the ex vivo IVD organ culture 
model with physiologically relevant mechanical loading, TGF-β1 supplement in the transplanted constructs 
induced the functional AF cell phenotype and enhanced collagen matrix synthesis. In conclusion, TGF-β1-
containing collagen-PU constructs could induce the functional cell phenotype of human AF cells in vitro and 
in situ. This combined cellular, biomaterial and bioactive agent therapy has a great potential for AF tissue 
regeneration and rupture repair.
Keywords: Annulus fibrosus, annular rupture repair, tissue engineering, transforming growth factor β1, 
polyurethane scaffold, collagen type I hydrogel.
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ACAN   aggrecan
ADAMTS5  a disintegrin and
    metalloproteinase with
    thrombospondin type I
    motifs, member 5
AF   annulus fibrosus
αMEM   alpha minimum essential
    medium
APC   allophycocyanin
BSA   bovine serum albumin
CCL4   hemokine (C-C motif)
    ligands 4
CD146   cluster of differentiation 146
COL1A2  collagen type I alpha 2
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COL1A1  collagen type I alpha 1
COL2A1  collagen type II alpha 1
DAPI   4′,6-diamidino-2-
    phenylindole
DMEM   Dulbecco’s modified Eagle
    medium
ECM   extracellular matrix
EDTA   ethylenediaminetetraacetic
    acid
ELN   elastin
EP    endplate
ERK   extracellular signal-
    regulated kinases
FACS   fluorescence-activated cell
    sorting
FAM   carboxyfluorescein
FBS   foetal bovine serum
FCS   foetal calf serum
GAG   glycosaminoglycan
HMDI   1,6-hexamethylene 
    diisocyanate
iAF   inner AF tissue
IVD   intervertebral disc
ISO   1,4,3,6-dianhydro-D-sorbitol
LBP   low-back pain
MMP3   matrix metalloproteinase 3
MKX   mohawk homeobox
MSCs   mesenchymal stem cells
MRI   magnetic resonance imaging
NEAA   non-essential amino acid
NP   nucleus pulposus
oAF   outer AF tissue
PBS   phosphate-buffered saline
PCL   poly(ε-caprolactone)
PU   polyurethane
PU-Col   PU scaffold-collagen
    hydrogel
PU-Col-AFCs  PU-Col with TGF-β1 pre-
    treated AF cells
PU-Col-AFCs-TGFβ PU-Col-AFCs and 5 ng 
    TGF-β1
qRT-PCR  quantitative real-time 
    polymerase chain reaction
RPLP0   ribosomal protein lateral
    stalk subunit P0
SCX   scleraxis
SM22α   smooth muscle protein
    22-alpha
TAMRA  tetramethylrhodamine
TGF-β1   transforming growth factor 
    β1
VCAN   versican
Introduction
LBP has become one of most common chronic 
health problems. Approximately 80 % of the 
population has been affected by LBP at least once in 
their life, representing a high economic and social 
burden (Dionne et al., 2006; Hoy et al., 2012; Hoy 
et al., 2010). IVD degeneration and disc herniation 
are well-known as leading causes of specific LBP 
(Roberts et al., 2006). In IVD herniation, the NP 
protrudes out of the defective AF and irritates and 
compresses the spinal nerves, resulting in pain and 
dysfunction. Furthermore, the integrity of the IVD is 
destroyed, which leads to mechanical property loss 
(consequently, reduced disc height), inflammation 
and further disc degeneration (Goupille et al., 1998; 
Humphreys and Eck, 1999). Microdiscectomy/
sequestrectomy is the standard surgical treatment 
for patients with severe dysfunction or without 
satisfactory outcomes after conservative therapy. The 
acute symptoms are relieved by removing herniated 
tissue. However, AF defects remain unrepaired, 
which leads to a 10-30 % re-herniation rate resulting 
in recurrent pain and continuing disc degeneration 
(Ambrossi et al., 2009; Carragee et al., 2003; Smith et 
al., 2010). Aggressive discectomy with removal of 
all NP material reduces the risk of re-herniation but 
will lead to a post-discectomy syndrome with rapid 
disc degeneration and pain in nearly one third of the 
patients (Watters and McGirt, 2009).
 Several attempts have been made at AF repair 
after discectomy, such as direct suture and 
conglutination with glue; however, outcomes have 
been unsatisfactory (Ahlgren et al., 2000; Bailey et 
al., 2013; Guterl et al., 2014; Heuer et al., 2008). The 
self-healing capacity of the AF tissue is confined 
due to its avascular nature. Additionally, with the 
IVD as a load-bearing tissue, the repair of the AF 
should not only restore its mechanical properties 
but also reproduce its biological integrity (Chu et al., 
2018). Tissue engineering has been demonstrated to 
be a prospective approach for AF repair in the last 
few decades (Agnol et al., 2018; Borem et al., 2017; 
Frauchiger et al., 2018; Hussain et al., 2018; Pirvu et 
al., 2015). However, appropriate cell sources, growth 
factors and biomaterials for generation of functional 
and integrated AF tissue analogues are still unmet 
needs.
 MSCs have been proposed as a suitable cell source 
for IVD regenerative therapies (Sakai and Grad, 2015). 
In an ovine lumbar disc degeneration model, injection 
of bone-marrow-derived MSCs into previously 
incised AF resulted in a significant improvement 
in histological, biochemical and MRI analyses 
(Freeman et al., 2016). Nevertheless, the fate of the 
implanted cells and their potential to differentiate 
into AF-like cells remain uncertain. In a previous 
study, MSCs were transplanted into AF defects of 
bovine caudal IVDs and cultured in an organ culture 
model under dynamic load for 14 d, to investigate 
the phenotype of MSCs after transplantation and 
their paracrine effect on native disc cells (Pirvu et al., 
2015). MSCs showed the ability to positively affect 
the phenotype of the host disc cells, as indicated 
by the up-regulation of anabolic genes and down-
regulation of catabolic genes. However, no effect was 
detected on new matrix formation at the AF defect 
site. This finding demonstrated that non-primed 
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MSCs have limited capacity to differentiate into 
AF cells in situ. An effective cell population with 
repair ability is required to reconstruct an AF tissue 
with normal functions. AF cells possess the innate 
capacity to rebuild the biological properties of tissue-
engineered AF analogues (Iu et al., 2017; Yang et al., 
2009). However, phenotypic markers of functional 
AF cells as a guideline for seed cell selection are 
still missing, except for collagen type I, which is the 
prominent ECM component in the AF. Recently, 
Nakai et al. (2016) have demonstrated that CD146+ 
murine AF cells deposit more collagen type I-rich 
ECM as compared with CD146− cells, indicating that 
CD146 may be a marker of functional AF cells. The 
present study unravelled further molecular markers 
of healthy AF cells as compared with NP cells. Then, 
these markers were used as indicators of functional 
AF cell induction.
 Several studies have shown that TGF-β1 enhances 
ECM production and cell proliferation of human 
AF cells in both 2D and 3D in vitro cultures (Chou 
et al., 2016; Gruber et al., 2004). TGF-β1 increases 
myofibroblast contractility in wound healing, which 
plays a pivotal role in physiological tissue remodelling 
(Tomasek et al., 2002). TGF-β1 can also prevent 
degenerative processes and inhibit inflammatory 
responses in the dorsal root ganglion and prevent 
pain development in a rat IVD degeneration model 
(Zhang et al., 2017). Therefore, the effect of TGF-β1 
on the expression of the functional markers in human 
AF cells was investigated. In addition to 2D and 3D 
in vitro culture systems, TGF-β1-treated AF cells were 
tested in a preclinical IVD organ culture model to 
reveal their repair effect in situ.
 In addition to cell source and growth factor, 
a biomaterial with appropriate biological and 
biomechanical compatibility is crucial for successful 
regeneration of AF tissue in situ. PU scaffolds have 
been reported to have excellent biocompatibility, 
mechanical property and stability for AF tissue 
engineering (Agnol et al., 2018; Yeganegi et al., 2010). 
Whatley et al. (2011) developed a PU scaffold to 
mimic the native shape and structure of the IVD 
that exhibited elastic behaviour during compressive 
and shear testing and supported cell growth. Lee 
et al. (2005) and Li et al. (2009) have performed 
research on PU scaffolds with an interconnected pore 
structure for cartilage tissue engineering. Results 
showed that PU scaffolds have sufficient elasticity, 
resiliency and stiffness to endure in vitro mechanical 
loading. Hydrogels such as collagen, agarose, fibrin 
and alginate are widely used to encapsulate and 
deliver cells into scaffolds, preventing cell loss 
from scaffold and enhancing the retention of matrix 
molecules (Alini et al., 2003). Collagen type I, the 
main component of AF ECM, has been coated on to 
plastic, promoting AF cell proliferation and matrix 
production in vitro (Xiao et al., 2017). A crosslinked 
collagen I hydrogel was injected to repair AF rupture 
in a punctured rat-tail model. Results showed that 
collagen gel can preserve the integrity of the AF 
and NP after needle puncture, while delaying the 
degeneration of the IVD (Wang et al., 2017). Bowles 
et al. (2010) found that a collagen I hydrogel seeded 
with ovine AF cells display a capacity for self-
assembly of aligned tissue-engineered AF through 
collagen gel contraction. Those studies indicated a 
good potential of collagen I hydrogel for AF cells 
proliferation and AF matrix synthesis. However, 
the specific phenotypes of the AF cells within these 
various biomaterials have not yet been reported.
 The current study aimed to define the functional 
markers of healthy AF cells and assess the in vitro 
and ex vivo effect of a bioactive agent-biomaterial 
approach for functional AF cells priming and AF 
rupture repair. First, the markers of functional AF 
cells were defined; then, potential cell sources (AF 
cells) with growth factor (TGF-β1) for functional 
phenotype induction were assessed; finally, those 
were combined with biomaterials. PU scaffolds with/
without collagen I hydrogel were assessed for their 
capacity to support and maintain the functional 
phenotype of AF cells in an in vitro 3D culture model 
and an ex vivo preclinical organ culture model. Cell 
proliferation, matrix production and gene expression 
were evaluated in vitro. Ex vivo tests were performed 
on bovine caudal IVDs with an organ culture system 
including a mechanical loading bioreactor. The 
morphology of regenerated tissue and the phenotype 
of implanted and native disc cells were analysed to 
assess the repair effect of constructs in an AF defect 
in situ.
Materials and Methods
Fabrication of PU scaffold and PU membrane
PU was synthesised using a one-step solution 
polycondensation as described previously (Gorna 
and Gogolewski, 2006). Briefly, the monomers and 
macromers used for the synthesis were HMDI 
(Sigma-Aldrich), hydroxyl-terminated PCL (Sigma-
Aldrich), with an average molecular weight of 
530 g/mol and a functionality of 2, and ISO (Sigma-
Aldrich). The reactants underwent a one-step 
polycondensation in solution in the presence of a 
catalyst. The HMDI : PCL : ISO molar ratio used was 
1 : 0.32 : 0.64. The PU obtained had intrinsic viscosity, 
weight average molecular weight and polydispersity 
of 1.3 dL/g, 500,000 g/mol and 2.00, respectively.
 Membranes were produced by casting the N,N-
dimethylformamide solution of the synthesised PU 
into a flat-bottom glass Petri dish and allowing the 
solvent to evaporate under a chemical hood. The 
measured ultimate strength of the PU membrane was 
53.0 ± 2.0 MPa, the yield strength 4.9 ± 1.4 MPa and 
the elongation at break 593.8 ± 57.7 %. The surface of 
the PU membrane did not present large porosity and 
was mostly smooth on the top and bottom (Pirvu et 
al., 2015).
 Porous PU sponges with interconnected pore 
size diameter of 150-300 µm were produced using 
4 www.ecmjournal.org
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a salt leaching-phase inverse fabrication extensively 
reported elsewhere (Boissard et al., 2009; Lee et 
al., 2005). Water-jet cutting was used to produce 
cylindrical scaffolds of 3 mm diameter, 4 mm 
thickness and scaffolds were sterilised by cold 
ethylene oxide and degassed for 5 d before use. The 
unconfined compressive stiffness of the prepared 
scaffolds was approximately 20 kPa (Grad et al., 2003).
Isolation and expansion of human AF cells
Human IVD tissue was harvested with ethical 
approval (Cantonal Ethics Commission Bern 2016) 
and written patient consent from traumatic injured 
IVDs (30-55 years old, 6 male donors), which were 
classified as mildly degenerated (Pfirrmann grade 
2-3). To ensure purity of AF samples, AF tissue 
was collected after removing all the adjacent NP 
tissue and cartilage EP. The collected AF tissue was 
incubated with red blood cell lysis buffer [155 mM 
NH4Cl, 10 M KHCO3 and 0.1 mM EDTA in Milli-Q 
water] for 5 min on a shaker at room temperature and, 
then, washed with PBS. Then, the chopped tissue was 
enzymatically digested for 1 h with 0.2 % w/v Pronase 
(Roche) in αMEM (Gibco), followed by 12-14 h at 
37 °C in 130 U/mL collagenase type II (Worthington) 
in αMEM/10 % FBS (PAN Biotech, Aidenbach, 
Germany). Single-cell suspension was obtained by 
filtering through a 100 µm cell strainer. Next, cells 
were seeded at a concentration of 10,000 cells/cm2 and 
expanded with αMEM supplemented with 10 % FCS, 
100 U/mL penicillin and 100 mg/mL streptomycin 
(1 % P/S, Gibco). Incubation conditions were set to 5 % 
CO2 at 37 °C at a hypoxic condition of 2 % O2. Culture 
medium was changed twice a week and cells were 
detached at ~ 80 % confluence using a dissociation 
buffer composed of 0.05 % trypsin/EDTA (Gibco) and 
0.01 % collagenase P (Roche) for 5 min at 37 °C. Cells 
were sub-cultured at a cell density of 3,000 cells/cm2 
for expansion in the same medium as above. Passage 
2 AF cells were used in the present study.
AF cells, 2D and 3D culture in vitro
2D culture in vitro
Passage 2 human AF cells were treated with either 
basal medium [αMEM, 5 % FBS, 1 % ITS+ (BD 
Biosciences), 1 % P/S] or TGFβ medium [basal 
medium with 5 ng/mL recombinant human TGF-β1 
(Fitzgerald, Acton, MA, USA)] for 4 d. Then, cells were 
dissociated for gene expression analysis, contractility 
study or flow cytometry analysis. AF cells pre-treated 
with TGFβ medium for 4 d were used for in vitro 
3D culture experiments and ex vivo organ culture 
experiments.
3D culture in vitro
PU scaffolds were pre-wetted for 1 h in αMEM 
with 10 % FBS under vacuum conditions. Medium 
was completely aspirated from the scaffolds, which 
were placed into 0.5 mL protein-low-binding 
Eppendorf tubes. Tubes were pre-coated for 1 h 
at 37 °C with 1 % BSA (Gibco). TGF-β1-treated 
AF cells were harvested and resuspended with 
medium or Corning® Collagen I, rat tail solution 
at a cell density of 2 × 105 cells per 30 µL. The final 
concentration of the collagen I hydrogel was 1.81 mg/
mL. For the TGF-β1 containing group, 5 ng TGF-β1 
was added within the AF-cells-collagen I solution 
suspension. Cell suspension in medium or collagen 
I solution was dropped onto the scaffold (30 µL per 
scaffold). Scaffolds were compressed mildly with 
forceps to allow cell suspension infiltration into the 
scaffold, then incubated for 1 h at 37 °C to allow 
cell adhesion and collagen-hydrogel gelation. Next, 
constructs were transferred into a 24-well plate and 
cultured at 37 °C, 5 % CO2, 2 % O2 in high-glucose 
DMEM supplemented with 1 % P/S, 2 % FBS, 50 mg/
mL L-ascorbic acid 2-phosphate (Sigma-Aldrich), 
1 % ITS+ and 1 % NEAA (Gibco). The medium 
volume was 1 mL per scaffold and it was replaced 
twice a week. After 7 d of culture, scaffolds were 
collected for gene expression analysis, DNA and 
GAG quantification and toluidine blue staining. 
For the ex vivo organ culture study, constructs were 
immediately implanted into the AF defect after 
gelation of the collagen type I hydrogel.
Bovine caudal IVD dissection
Caudal IVDs were harvested from 6-12-month-
old calves obtained from a local abattoir after 
sacrifice. Disc dissection was performed as described 
previously (Lang et al., 2018). IVDs with cartilage 
EPs were isolated using a band saw, then scraped 
using a scalpel to remove the vertebral bone and 
growth plate and ensure two parallel planes of disc. 
EP surfaces were cleaned with Ringer’s balanced 
salt solution using a Pulsavac Wound Debridement 
Irrigation System (Zimmer, Minneapolis, MN, USA) 
to remove cutting debris and blood clots. IVDs were 
pre-washed in PBS with 10 % P/S (Gibco) at room 
temperature for 20 min, then cultured at 37 °C 5 % 
CO2 in 6-well plates with 7.5 mL IVD culture medium: 
high-glucose DMEM supplemented with 1 % P/S, 
50 mg/mL Primocin (Invitrogen), 2 % FBS, 50 mg/
mL ascorbate-2phosphate, 1 % ITS+ and 1 % NEAA. 
Culture medium was replaced every day.
 Different parts of healthy IVD tissue, including NP 
tissue (gel-like inner core of 6-8 mm diameter), outer 
AF tissue (oAF, distinguishable lamellar AF tissue, 
ring at thickness ~ 4 mm) and inner AF tissue (iAF, 
located between NP and oAF) from 6 bovine tails 
(age 6-12 months) were collected for gene expression 
analysis on day 0, to measure the expression level of 
potential AF markers (Table 1).
Annulotomy model for preclinical testing of AF 
repair therapy in whole-organ IVD culture
24 caudal IVDs were dissected from 4 bovine tails 
(age 6-12 months). Day 0 control group comprised 4 
IVDs. AF defect repair groups comprised 6 IVDs per 
group and consisted of 1) an acellular PU scaffold-
collagen hydrogel (PU-Col), 2) PU-Col with TGF-β1 
pre-treated AF cells (PU-Col-AFCs) and 3) PU-Col 
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Table 1. Oligonucleotide primers and probes (bovine and human) used for qRT-PCR. Primers and probes 
with the sequence shown were custom designed; primers and probes with the catalogue number were from 
Applied Biosystems. fw: forward; rev: reverse; b: bovine; h: human.
Gene Primer/probe type Sequence
bCOL1A2
Primer fw (5′-3′) TGC AGT AAC TTC GTG CCT AGC A
Primer rev (5′-3′) CGC GTG GTC CTC TAT CTC CA
Probe (5′FAM/3′TAMRA) CAT GCC AAT CCT TAC AAG AGG CAA CTG C
bCOL2A1
Primer fw (5′-3′) AAG AAA CAC ATC TGG TTT GGA GAA A
Primer rev (5′-3′) TGG GAG CCA GGT TGT CAT C
Probe (5′FAM/3′TAMRA) CAA CGG TGG CTT CCA CTT CAG CTA TGG
bACAN
Primer fw (5′-3′) CCA ACG AAA CCT ATG ACG TGT ACT
Primer rev (5′-3′) GCA CTC GTT GGC TGC CTC
Probe (5′FAM/3′TAMRA) ATG TTG CAT AGA AGA CCT CGC CCT CCA T
bMMP3
Primer fw (5′-3′) GGC TGC AAG GGA CAA GGA A
Primer rev (5′-3′) CAA ACT GTT TCG TAT CCT TTG CAA
Probe (5′FAM/3′TAMRA) CAC CAT GGA GCT TGT TCA GCA ATA TCT AGA AAA C
bADAMTS5
Primer fw (5′-3′) GAT GGT CAC GGT AAC TGT TTG CT
Primer rev (5′-3′) GCC GGG ACA CAC CGA GTA C
Probe (5′FAM/3′TAMRA) AGG CCA GAC CTA CGA TGC CAG CC
bCD146 Bt03258894_m1
bSM22α  Bt03234600_m1
bSCX Hs03054634_g1
bMKX  Bt04292311_m1
bELN Bt03216594_m1
bVCAN  Bt03217632_m1
bRPLP0 Bt03218086_m1
hCOL1A1
Primer fw (5′-3′) CCC TGG AAA GAA TGG AGA TGA T
Primer rev (5′-3′) ACT GAA ACC TCT GTG TCC CTT CA
Probe (5′FAM/3′TAMRA) CGG GCA ATC CTC GAG CAC CCT
hCOL2A1
Primer fw (5′-3′) GGC AAT AGC AGG TTC ACG TAC A
Primer rev (5′-3′) GAT AAC AGT CTT GCC CCA CTT ACC
Probe (5′FAM/3′TAMRA) CCT GAA GGA TGG CTG CAC GAA ACA TAC
hACAN
Primer fw (5′-3′) AGT CCT CAA GCC TCC TGT ACT CA
Primer rev (5′-3′) CGG GAA GTG GCG GTA ACA
Probe (5′FAM/3′TAMRA) CCG GAA TGG AAA CGT GAA TCA GAA TCA ACT
hMMP3 Hs00968305_m1
hADAMTS5  Hs01095518_m1
hCD146 Hs00174838_m1
hSM22α  Hs00162558_m1
hSCX Hs03054634_g1
hMKX  Hs00543190_m1
hELN Hs00355783_m1
hVCAN  Hs00171642_m1
hRPLP0
Primer fw (5′-3′) TGG GCA AGA ACA CCA TGA TG
Primer rev (5′-3′) CGG ATA TGA GGC AGC AGT TTC
Probe (5′FAM/3′TAMRA) AGG GCA CCT GGA AAA CAA CCC AGC
6 www.ecmjournal.org
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with TGF-β1 pre-treated AF cells and 5 ng TGF-β1 
(PU-Col-AFCs-TGFβ). Within the 6 replicates in 
each group, 4 IVDs were used for gene expression 
analysis of human AF cells in scaffold and native 
IVD tissue and 2 IVDs were used for safranin O/fast 
green staining. 2 IVDs served as non-repair negative 
control on day 15 and were used for safranin O/fast 
green staining.
 The IVD AF defect was created with a biopsy 
punch (diameter 3 mm, length 7 mm). Full thickness 
of AF tissue and some NP tissue were removed. Then, 
the defect was refilled with different scaffolds, as 
described above. A PU membrane (12 × 7 mm) was 
affixed to the IVD with 2 µL of EPIGLU® (Meyer-
Haake GmbH, Ober-Mörlen, Germany) surrounding 
the defect area, to maintain the scaffold within the 
defect. IVDs were cultured in IVD culture medium 
and loaded with physiological compressive loading 
for 1 h at 0.02-0.2 MPa, 0.2 Hz daily within a bioreactor 
(Lang et al., 2018). The disc height was measured 
using a caliper at 2 positions to calculate percentage 
change normalised to day 0 after dissection. After 
14 d of culture, IVDs were collected for evaluations.
Flow cytometry analysis
TGF-β1-treated and -non-treated AF cells were 
harvested by trypsinisation. Single-cell suspension 
was prepared at a cell density of 1 × 105 cells per 
100 µL staining buffer (PBS with 0.2 % BSA and 
1 mM EDTA). Cell suspensions were incubated at 
4 °C in the dark for 30 min with 10 µL fluorescence-
conjugated mouse monoclonal anti-human CD146 
antibody (CD146-APC, human, Miltenyi Biotec) or 
10 µL mouse IgG1-APC (isotype control, Miltenyi 
Biotech). After incubation and washing, DAPI at 
a final concentration of 0.1 µg/mL was added for 
live/dead staining. Flow cytometric analysis was 
performed on a FACS AriaIII (BD Biosciences) and 
at least 30,000 events per sample were recorded. 
Data analysis was performed using BD FACSDiva 
software. A gating strategy was used to exclude dead 
cells and cell doublets.
Gene expression analysis
RNA isolation from 2D-cultured AF cell samples was 
performed using TRI reagent (Molecular Research 
Centre Inc., Cincinnati, OH, USA) according to the 
manufacturer’s protocol. AF cells in PU scaffold-
collagen type I hydrogel constructs were placed 
into 1 mL TRI reagent with 5 µL polyacryl carrier 
(Molecular Research Centre Inc.) and homogenised by 
a tissue-lyser (Retsch GmbH, Haan, Germany). After 
centrifugation at 12,000 ×g for 15 min, the supernatant 
was collected in a fresh EP tube and the RNA isolation 
was performed according to the manufacturer’s 
protocol. Native IVD tissues, including NP and AF in 
intact discs, as well as AF tissue adjacent and opposite 
to the repair constructs, were collected on day 0 
and 14. Tissues of 150-200 mg/sample were cut into 
small pieces and snap-frozen by liquid nitrogen and 
hammering (Caprez Stephanie, 2018). Then, tissues 
were transferred into 3 mL TRI reagent with 15 µL 
polyacryl carrier. Samples were homogenised using 
a tissue-lyser. After centrifugation, the supernatant 
was extracted by phase separation by adding 100 µL 
bromochloropropane per 1 mL of TRI reagent. The 
aqueous phase after centrifugation was transferred 
to a fresh tube and mixed with the same volume of 
70 % ethanol. Then, RNA isolation was performed 
using the QIAGEN RNeasy MINI kit according to 
the manufacturer’s protocol. Reverse transcription 
was performed using SuperScript® VILO™ cDNA 
Synthesis Kit (Invitrogen).
 qRT-PCR was conducted on QuantStudio6 System 
(Applied Biosystems). Sequences of the primers and 
probes used in qRT-PCR of bovine and human cells/
tissue are listed in Table 1. RPLP0 ribosomal RNA 
was used as endogenous control. Data were analysed 
using the 2−ΔΔCT method.
Cell contraction functionality assay
Contractility of TGF-β1-treated and -non-treated 
cells was evaluated by a cell contraction assay in 
collagen I hydrogel. A 24-well plate was coated with 
1 % BSA and incubated at 37 °C for at least 1 h. Cells 
from 3 donors were encapsulated in 1.81 mg/mL type 
I collagen with 4 technical replicates at a seeding 
density of 1.5 × 105 cells/mL. Cells were cultured at 
37 °C 2 % O2 in αMEM with 10 % FBS. After 24 h, 
gels were photographed (Canon PowerShot SX50 
HS) and well and gel diameters measured using NIS-
Elements D 3.2 (NIKON Japan). Two gel diameters 
were averaged to calculate the gel area. The gel area 
after 24 h was divided by the well area, calculated 
from the well diameter.
Toluidine blue staining
Cell distribution and ECM deposition within PU 
scaffold with or without hydrogel were evaluated 
by toluidine blue staining. Samples at day 1 and 7 
were snap-frozen in cryo-compound (Leica). Vertical 
sections of scaffold were made at a thickness of 
12 µm. Slides were fixed in 70 % methanol for 10 min, 
100 % methanol for 10 min, dried overnight, stained 
with 0.1 % toluidine blue for 2 min and rinsed with 
deionised water (4-5 times).
Safranin O/fast green staining
IVD samples after 14 d of culture were snap-frozen in 
cryo-compound after removal of the cartilage EP from 
one side. IVD transverse cryo-sections were made at a 
thickness of 12 µm. Slices were fixed as above, stained 
with 0.1 % safranin O and 0.02 % fast green to reveal 
proteoglycan and collagen deposition, respectively, 
and counterstained with Weigert’s haematoxylin to 
reveal cells distribution (Lang et al., 2018).
 Cell density in the implanted constructs was 
calculated using the safranin O/fast green-stained 
images. High-magnification images (676 × 536 µm) 
were taken at 6 random positions of each slide, with 
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2 slides per IVD and 2 IVDs per group. In total, cells 
from 24 images of each group were counted by Image 
J 1.52a (NIH).
GAG and DNA content measurement
Cell-scaffold constructs after 7 d of culture were 
digested overnight at 56 °C with 0.5 mg/mL 
proteinase K (Roche, Mannheim, Germany) solution. 
DNA content was measured using the PicoGreen 
kit (Invitrogen) according to the manufacturer’s 
instruction. GAG content was determined by 
dimethylmethylene blue assay (1.9-DMMB; Sigma-
Aldrich).
Statistical analysis
Statistical analyses were performed using GraphPad 
Prism 7 software (GraphPad Software, Inc., La Jolla, 
CA, USA). D’Agostino-Pearson omnibus normality 
test was used to define whether the data were 
normally distributed. For data that were normally 
distributed, unpaired t-test was used to determine 
differences between two groups; one-way ANOVA 
was used to determine differences between three 
or more groups. For data that were not normally 
distributed, Mann-Whitney U test was used to 
determine differences between two groups; Kruskal 
Wallis test was used to determine differences between 
three or more groups. p < 0.05 was considered 
statistically significant.
Results
Phenotype markers of AF cells
Phenotype markers of AF cells were defined by 
comparison of the gene expression levels in different 
parts of bovine IVD tissue. Compared with NP tissue 
and iAF, oAF expressed higher levels of COL1A2 
(p < 0.05), CD146 (p < 0.05), SM22α (p < 0.05) and MKX 
(p < 0.05) (Fig. 1), which were, therefore, defined as 
phenotype markers of healthy and functional AF 
cells. Furthermore, oAF tissue expressed lower levels 
of COL2A1 (p < 0.001), ACAN (p < 0.001) and SCX 
(p < 0.001) as compared with NP tissue. Interestingly, 
the transient zone iAF tissue showed a comparable 
gene expression pattern to NP tissue, except for lower 
levels of CD146 (p < 0.001).
Induction of the functional human AF cell 
phenotype for AF repair – in vitro 2D culture
To evaluate the functional phenotype of human AF 
cells induced by TGF-β1, gene expression levels 
of the AF markers were measured in human AF 
cells cultured with or without 5 ng/mL TGF-β1 for 
4 d, since cells reached 70-80 % confluency after 
4 d of culture, which is the optimal time point for 
cell trypsinisation and seeding on to the scaffold 
(Fig. 2a). mRNA levels of CD146 (p < 0.05), SM22a 
(p < 0.01), SCX (p < 0.01), MKX (p < 0.01) and COL2A1 
(p < 0.01) were significantly upregulated by TGF-β1 
treatment. CD146 upregulation at the protein 
level was confirmed by flow cytometry (Fig. 2b,c). 
The percentage of CD146+ cells in 4 donors was 
30.50 ± 14.55 % in basal medium, which increased to 
72.25 ± 22.02 % in TGFβ medium. In contrast, ECM 
degrading enzymes, MMP3 (p < 0.001) and ADAMTS5 
(p < 0.001), were downregulated by TGF-β1 treatment 
(Fig. 2a). Cell contractility was determined in collagen 
I hydrogel by measuring the surface area of the 
collagen gel after 24 h of incubation, as a functionality 
test. TGFβ medium induced a larger reduction of the 
gel area (22.8 ± 8.1 %) as compared with basal medium 
(38.3 ± 5.9 %) (Fig. 2d,e), which indicated a higher cell 
contractility after TGF-β1 treatment.
Preservation of the functional human AF cells 
phenotype for AF repair – in vitro 3D culture
To assess cell phenotype and tissue construction 
capabilities of induced functional human AF cells 
in an in vitro 3D model, human AF cells pre-treated 
with TGF-β1 for 4 d were seeded on to PU scaffold 
only (PU-AFCs) or PU scaffold-collagen I hydrogel 
constructs with (PU-Col-AFCs-TGFβ) or without 
(PU-Col-AFCs) 5 ng TGF-β1 supplement. Gene 
expression was measured at day 7, cell proliferation 
and matrix production both at day 1 and 7 after cell 
Fig. 1. Relative mRNA expression 
in NP, iAF and oAF from healthy 
bovine IVDs. Data were normalised 
to the expression level of NP tissue. 
n = 6, # p < 0.1, * p < 0.05, *** p < 0.001 vs. 
gene expression level in NP, § p < 0.05, 
§§ p < 0.01 comparing iAF and oAF.
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seeding, to investigate the effect of the cell carrier on 
functional AF cell phenotype maintenance and AF 
tissue regeneration.
 AF cells were evenly distributed in the PU 
scaffold both with or without collagen I hydrogel at 
day 1 after seeding (Fig. 3a-c). After 7 d of culture, 
higher cell density and more intense ECM staining 
were observed in PU-Col-AFCs-TGFβ (Fig. 3f) 
as compared to the other two groups (Fig. 3d,e), 
especially around the outer surface of the PU scaffold. 
Furthermore, DNA and GAG content and GAG/DNA 
ratio were significantly higher in the PU-Col-AFCs-
TGFβ scaffold when compared with PU-Col-AFCs 
(Fig. 3g-i). When comparing day 7 with day 1, DNA 
and GAG content and GAG/DNA ratio increased 
only in the PU-Col-AFCs-TGFβ group.
 Gene expression levels were evaluated in PU-
AFCs, PU-Col-AFCs and PU-Col-AFCs-TGFβ after 
7 d of culture and data were normalised to PU-AFCs. 
AF cells in PU-Col-AFCs and PU-Col-AFCs-TGFβ 
expressed higher levels of COL2A1, CD146, SM22a, 
SCX and MKX and lower levels of MMP3 and 
ADAMTS5 when compared with PU-AFCs (Fig. 
4). TGF-β1 supplementation into the PU scaffold-
collagen I hydrogel did not further affect the gene 
expression profile of AF cells as compared with the 
PU-Col-AFCs group.
AF rupture repair – preclinical testing in ex vivo 
IVD organ culture system
To test the property of the constructs in a preclinical 
organ culture model, annulotomised IVDs were 
repaired with PU scaffold-collagen hydrogel (PU-
Col) or PU-Col with AF cells with (PU-Col-AFCs-
TGFβ) or without (PU-Col-AFCs) 5 ng TGF-β1. 
Then, IVDs were cultured under physiological 
Fig. 2. Phenotype of human AF cells after treatment with TGF-β1 for 4 d. (a) Relative mRNA expression, 
data were normalised to basal medium. (b) Representative and (c) average percentage of CD146+ cells 
detected by flow cytometry. (d,e) Cell contractibility of AF cells cultured with basal or TGFβ medium. Mean 
+ SD; n = 4, * p < 0.05, ** p < 0.01, *** p < 0.001 vs. cells treated with basal medium.
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loading condition for 2 weeks, mimicking the in situ 
microenvironment for testing of AF rupture repair. 
The disc height change was measured during the 
whole culture period (Fig. 5). At day 2, disc height 
slightly increased for all groups after overnight free 
swelling as compared with day 0. Dynamic loading 
for 1 h caused a physiological disc height loss in all 
groups repaired with implants: PU-Col 8.6 ± 2.9 %, 
PU-Col-AFCs 8.6 ± 1.0 %, PU-Col-AFCs-TGFβ 
6.8 ± 1.4 %. After 14 d of repetitive dynamic loading, 
IVDs showed about 2 % of further disc height loss: 
PU-Col 10.8 ± 1.9 %, PU-Col-AFCs 10.2 ± 1.5 %, 
PU-Col-AFCs-TGFβ 8.4 ± 2.2 %. However, all IVDs 
recovered after free swelling. After 15 d culture with 
daily dynamic loading, no significant disc height 
loss was observed. Cell implantation and TGF-β1 
supplementation did not show any effect on disc 
height change under dynamic loading.
 Safranin O/fast green staining of transverse IVD 
sections after 15 d of culture is shown in Fig. 6. Part 
of the NP tissue protruded into the AF defect region 
in the injury control group without repair (Fig. 
6a). In all IVDs repaired with PU scaffold-collagen 
hydrogel (PU-Col cell-free, PU-Col-AFCs and PU-
Col-AFCs-TGFβ), NP tissue was maintained in its 
native position (Fig. 6b-d). When the AF defect was 
repaired with PU-Col scaffold without AF cells (Fig. 
6b,e), after 15 d of culture, no fast-green staining 
could be detected at the defect site. When the defect 
was repaired with PU-Col scaffold with AF cells (Fig. 
6c,f), AF cells were found in the scaffold after 15 d 
of culture. Collagen staining with fast green was 
Fig. 3. 3D culture of human AF cells in vitro. (a-f) Representative toluidine-blue-stained sections of 
scaffolds. TGF-β1-pre-treated human AF cells seeded on to (a,d) scaffolds PU-AFCs, (b,e) PU-Col-AFCs 
and (c,f) PU-Col-AFCs-TGFβ after 1 and 7 d. Scale bar: 500 µm. (g) DNA content, (h) GAG content and (i) 
GAG/DNA ratio in scaffolds after 1 and 7 d of culture. Mean + SD, n = 6, # p < 0.1, * p < 0.05. 
10 www.ecmjournal.org
J Du et al.                                                                                                  Functional cell-material therapy for AF repair
Fig. 4. Gene expression of human 
AF cells 3D-cultured in vitro. 
Relative mRNA expression of 
TGF-β1-pre-treated human AF 
cells seeded on to PU scaffold only 
(PU-AFCs), PU scaffold-collagen I 
hydrogel construct (PU-Col-AFCs) 
and PU-Col scaffold supplemented 
with 5 ng TGF-β1 (PU-Col-AFCs-
TGFβ) after 7 d of culture. Data 
were normalised to expression 
level of PU-AFCs. n = 6, * p < 0.05, 
** p < 0.01, *** p < 0.001 vs. gene 
expression levels of PU-AFCs. 
Fig. 5. Disc height change during 
15 d organ culture. Disc height 
change relative to initial dimension 
after dissection (day 0) at different 
time points: after free swelling 
culture overnight and after dynamic 
loading over 15 d of organ culture. 
PU-Col: annulotomised IVDs 
implanted with PU-Col scaffold; 
PU-Col-AFCs: PU-Col scaffold 
seeded with AF cells; PU-Col-AFCs-
TGFβ: PU-Col-AFCs supplemented 
with TGF-β1. Mean + SD, n = 6. 
*** p < 0.001 vs. disc height on day 0. 
also detected at the defect site. Furthermore, when 
TGF-β1 was supplemented in the collagen hydrogel 
(Fig. 6d,g), a higher cell density and stronger collagen 
staining intensity was observed at the defect site. The 
average cell number in high magnification visual 
fields was significantly higher in PU-Col-AFCs-TGFβ 
as compared with PU-Col-AFCs (p < 0.001) (Fig. 6h).
 Gene expression levels of implanted AF cells 
after 15 d of organ culture was analysed (Fig. 7). 
Results showed that COL1A1 (p < 0.01) expression 
was significantly higher in PU-Col-AFCs-TGFβ as 
compared with PU-Col-AFCs, which correlated 
with the fast green staining results. There was also a 
trend for increased CD146 (p < 0.1) and ELN (p < 0.1) 
expression by TGF-β1 supplementation in the 
collagen gel. Gene expression levels in the native IVD 
tissues, including AF close to PU scaffold, NP tissue 
and AF opposite PU scaffold, were also measured 
after 15 d of organ culture. No significant difference 
was found among the 3 repaired groups (Fig. 8).
Discussion
There is an unmet clinical need for AF rupture repair, 
especially for large AF defects. Tissue engineering 
AF for large AF rupture repair is considered to be a 
promising approach to prevent disc re-herniation and 
associated discogenic pain and to reconstitute the disc 
biological and mechanical function (Chu et al., 2018; 
Iatridis et al., 2013; Sloan et al., 2018).
 A clear understanding of markers related to 
the healthy and functional AF cell phenotype is 
fundamental to define proper cell sources for AF 
tissue regeneration. However, there is surprisingly 
limited research on AF cell phenotype so far (Pattappa 
et al., 2012; Torre et al., 2019). In the current study, the 
expression profile of several potential phenotypic 
markers of functional AF cells was measured in 
healthy oAF tissue as compared with iAF and NP 
tissue. COL1A2, CD146, SM22α and MKX were 
most highly expressed in the oAF (Fig. 1). Thus, 
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they were defined as markers of functional AF cells 
(Bron et al., 2009; Costi et al., 2007; Nakamichi et al., 
2016; Schmidt et al., 2007). Each of these markers had 
previously been shown to be related to AF tissue 
function. Collagen type I expression at both gene 
and protein level is a well-known marker of AF cells 
in all species related with the tissue ECM property, 
since the proportion of collagen type I increases from 
the NP towards the outer AF (Bron et al., 2009). MKX 
expression at both gene and protein level has recently 
been identified as a transcription factor for AF cell 
differentiation, where MKX knock-out mice showed 
a much smaller collagen fibril diameter and a more 
rapid IVD degeneration as compared with the wild 
type mice (Nakamichi et al., 2016). Nakai et al. (2016) 
found that CD146 and SM22α are co-expressed in the 
mouse oAF tissue, which may be correlated with the 
maximum shear strain in the oAF tissue under lateral 
bending of IVD (Costi et al., 2007; Schmidt et al., 2007). 
Interestingly, the expression level of CD146 in iAF 
was significantly lower than in NP. The exact reason 
is unclear, since few studies have reported CD146 
expression in NP tissue and  in iAF tissue. Milinos 
et al. (2015) found that 22.3 % of bovine primary NP 
cells are positive for CD146 FACS staining, while 
in human primary NP cells, CD146 expression is 
not detected on the cell surface (Sakai et al., 2012). 
Based on the results from the current study, CD146 
may serve as a candidate marker to distinguish NP 
and iAF. However, further studies are needed with 
a larger sample size and the protein expression 
should be confirmed. The current study, for the 
first time, systematically measured and identified 
these molecules as a marker pool for functional AF 
cells. These markers were defined in healthy bovine 
tissue due to very limited access to healthy human 
IVD tissue with good zonal structures. Some of the 
markers have been reported to be relevant to AF 
function in human and other species, as discussed 
above. Therefore, they were expected to be similar 
between bovine and human species and were used 
as a guideline for cell induction with human AF cells.
 In previous studies, TGF-β1 was shown to increase 
collagen type I and II as well as GAG production in 
a rat foetal AF cell micromass model; additionally, 
it tended to promote cell proliferation (Hayes and 
Ralphs, 2011). Blanquer et al. (2017) reported that 
TGF-β3 is essential to support AF differentiation 
of human adipose stem cells. However, the effects 
of TGF-β on the functional properties of AF cells 
and cell fate of MSCs were not clear, as markers 
of functional AF cells were not tested in those 
studies. The present study results corroborated the 
hypothesis that TGF-β1 induced a functional AF cell 
phenotype in human mildly degenerated AF cells, as 
indicated by upregulated expression of phenotypic 
markers (CD146, SM22α and MKX) and increased 
cell contractility. These results indicated that TGF-
β1-induced AF cells from mildly degenerated disc 
tissue may be used as a cell source for AF rupture 
repair. It would be meaningful to further investigate 
the effect of TGF-β1 on AF phenotype differentiation 
of MSCs under an appropriate microenvironment, 
which may expand the cell source options with an 
easily accessible endogenous cell type.
 Interestingly, results showed that TGF-β1 induced 
COL2A1 expression in human AF cells under in vitro 
2D culture condition (Fig. 2a). However, in the ex 
Fig. 6. Representative safranin O/fast green-stained sections of IVDs after 15 d organ culture. (a) 
Annulotomised discs and annulotomised discs repaired with (b,e) PU-Col cell-free, (c,f) PU-Col scaffold 
seeded with TGF-β1-pre-treated AF cells (PU-Col-AFCs) and (d,g) PU-Col-AFCs supplemented with 
TGF-β1 (PU-Col-AFCs TGFβ), cultured for 15 d under dynamic load. (h) Cell numbers counted from the 
high magnification images in safranin O/fast green-stained sections. Mean + SD, n = 24, *** p < 0.001 vs. 
PU-Col-AFCs. Scale bar: (a-d) 500 µm, (e-g) 100 µm. Yellow arrows indicate cells. 
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vivo organ culture study, addition of TGF-β1 within 
the hydrogel induced COL1A1 expression of human 
AF cells (Fig. 7), highlighting the context-specific 
behaviours of TGF-β1. These results indicated that 
the native AF tissue microenvironment in situ may 
orient the effect of TGF-β1 towards the native cell 
phenotype. ELN expression was also upregulated in 
implanted AF cells by TGF-β1 supplementation (Fig. 
7), which plays an important role in maintenance 
of collagen organisation and recovery of the disc 
size and shape after deformation (Yu et al., 2002). 
Nakai et al. (2016) showed that ELN upregulation in 
CD146+ AF cells may contribute to the development 
of a contractile phenotype in these AF cells. SCX, a 
basic helix-loop-helix transcription factor that marks 
the tendon/ligament cell lineage and is present in 
the AF (Pryce et al., 2007; Yoshimoto et al., 2017), 
was highly upregulated in both 2D and 3D cultures 
treated with TGF-β1 (Fig. 2a, 4). Interestingly, it had 
lower expression in oAF vs. NP in bovine IVD (Fig. 
1). However, SCX+ AF cells function in healing of AF 
rupture in neonatal mice (Torre et al., 2018), which 
may explain the low expression level in mature 
bovine AF tissue. IVD cells fail to maintain the 
balance of anabolism and catabolism during ageing 
and degeneration, with decreased ECM synthesis and 
increased ECM degrading enzymes, such as MMP 
and ADAMTS family. The upregulation of MMP3 
and ADAMTS5 has been reported in degenerated 
IVDs (Vo et al., 2013). Present results showed that 
TGF-β1 not only upregulated ECM production but 
also downregulated the expression of ECM catabolic 
enzymes MMP3 and ADAMTS5 (Fig. 2a, 4). This 
indicated that TGF-β1-treated AF cells may possess 
an anti-catabolic effect in AF rupture repair for 
prevention of further tissue degeneration. When AF 
cells were cultured in collagen I hydrogel both in vitro 
and ex vivo, higher cell density was found in TGF-β1-
supplemented scaffolds (Fig. 3,6), which indicated 
that TGF-β1 promoted cell proliferation and/or cell 
survival of human AF cells. This is essential for 
rebuilding of the biological function when cells are 
implanted into the avascular disc milieu. In summary, 
results showed that TGF-β1 was an effective agent for 
biological functional recovery of AF.
 PU materials are promising biomaterials for 
AF regeneration, as they are biodegradable, 
biocompatible, mechanically robust and elastic 
(Agnol et al., 2018; Yeganegi et al., 2010). In the present 
study, AF cells were evenly distributed within the 
porous PU scaffold, with or without collagen gel as 
a cell carrier (Fig. 3a-c). Furthermore, the scaffold 
size can be easily tuned for custom-designed patient 
need in further application. Type I collagen is a 
component of AF matrix and was used to deliver 
the functional AF cells in PU scaffold and create a 
biomimetic environment of AF. Collagen type I has 
been reported to promote AF cells proliferation and 
matrix production in vitro (Xiao et al., 2017). Present 
results showed that collagen I hydrogel maintained 
AF cell survival after 7 d of 3D culture in vitro but did 
not further enhance cell proliferation. Importantly, 
collagen I hydrogel as a cell carrier could preserve 
the functional phenotype of TGF-β1-induced human 
AF cells, as indicated by higher expression level 
of CD146, SM22α and MKX as compared with PU 
scaffold only (Fig. 4). These results demonstrated 
the potential capacity of collagen I hydrogel for cell 
delivery and functional phenotype maintenance in 
AF rupture repair.
 In the ex vivo preclinical study, AF defects were 
repaired with PU-Col constructs and PU membrane 
sealing. After 14 d of organ culture under daily 
dynamic loading, PU-Col constructs could still 
completely fill the AF defect and no herniation of 
NP tissue was found. While in injury control discs, 
part of the NP tissue protruded into the AF defect 
area (Fig. 6). Implantation of AF cells into the AF 
Fig. 7. Relative mRNA expression 
of human AF cells  which were 
encapsulated in implants after 15 d 
organ culture. AF cells were encapsulated 
in PU-Col scaffold (PU-Col-AFCs) or PU-
Col scaffold supplemented with TGF-β1 
(PU-Col-AFCs-TGFβ) and implanted 
into AF defect, cultured for 15 d in 
situ with dynamic loading. Data were 
normalised to expression level of PU-
Col-AFCs. n = 4, # p < 0.1, ** p < 0.01 vs. 
gene expression levels of PU-Col-AFCs.
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defect was carried out by delivering them in PU-Col 
constructs. After 14 d of in situ culture with daily 
dynamic load, the implanted AF cells remained in 
the PU-Col constructs and started matrix production. 
Interestingly, cell density and matrix production were 
more pronounced when TGF-β1 had been added in 
the constructs. On the other hand, cells expressed 
significantly higher COL1A1 and showed a trend for 
higher levels of CD146 and ELN in TGF-β1-supplied 
constructs. These results indicated that TGF-β1 
administration within the selected biomaterial could 
better facilitate the enhancement of functional AF 
cell phenotype and neo-tissue formation in situ. 
Pirvu et al. (2015) showed that implantation of MSCs 
positively modulates cell phenotype of host disc 
tissue by up-regulating anabolic mechanisms and 
down-regulating catabolic mechanisms by paracrine 
effect. However, there was no evidence showing 
the same effect on native disc tissue with AF cells 
implantation (Fig. 8); while new matrix production 
was only observed with the functional AF cells 
implantation. These findings suggested that MSCs 
and AF cells had different mechanisms of action. 
MSCs, which can be derived from a wide range of 
sources, can positively modulate cells of the host 
disc tissue, but may have limited potential for AF 
matrix production. In contrast, AF cells are suitable 
for neo-tissue formation, but do not influence the 
phenotype of adjacent host cells. To further improve 
the homeostasis in AF tissue repair and prevent 
further IVD degeneration, combination of functional 
AF cells and the effective paracrine factors from MSCs 
may bring further valued outcomes.
 The limitations of the current study remain in the 
following aspects: the random porous architecture 
of the PU scaffold likely did not promote matrix 
deposition in an angle-plied lamellar microstructure 
similar to that of native AF fibres, despite its good 
cell seeding capacity. Implementation of additive 
manufacturing for production of PU scaffolds may 
further promote maintenance/induction of the 
functional AF cell phenotype and formation of a 
native-mimicking ECM structure. Both in vitro and 
ex vivo studies were performed with 2 weeks follow-
up. Further longer follow-up study may be needed 
to evaluate long-term culture properties such as cell 
survival, ECM production and degradation of PU 
scaffold. Additional studies with high force, fatigue 
and complex loading to evaluate herniation risk 
of the construct are needed. Ultimately, in vivo, a 
higher load is expected in the disc. A press-fit and 
biocompatible material filler is needed to close the 
defect and restore the mechanical function of the 
IVD with high adhesion strength and adequate 
compressive, shear and tensile moduli (Long et al., 
2016), to provide structural support for the biological 
repair.
Fig. 8. Relative mRNA expression of host disc tissue after 15 d of organ culture. Relative mRNA expression 
in (a) NP, (b) adjacent AF and (c) distal AF tissue of discs repaired with PU-Col cell-free (PU-Col), PU-Col 
scaffold seeded with TGF-β1-pre-treated AF cells (PU-Col-AFCs) and PU-Col-AFCs supplemented with 
TGF-β1 (PU-Col-AFCs-TGFβ) after 15 d of organ culture with dynamic loading. Data were normalised to 
the expression level of PU-Col. n = 4. (d) Transverse schematic view of discs implanted with scaffolds and 
disc tissue collected for gene expression analysis.
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Conclusions
The current study explored a novel AF repair strategy 
aiming at functional cell phenotype induction. A set 
of AF cell phenotype markers were defined in healthy 
AF tissue as compared with NP, including COL1A2, 
CD146, SM22α and MKX. TGF-β1 upregulated gene 
and protein expression of the AF cell markers in 
human mildly degenerated AF cells and increased 
cell contractility, indicating that TGF-β1-pre-treated 
AF cells may be an appropriate cell source for AF 
tissue engineering or rupture repair. Collagen 
type I hydrogel as a cell carrier in the PU scaffold 
maintained the phenotype of human AF cells. TGF-β1 
treatment within the collagen hydrogel further 
promoted cell proliferation and matrix production of 
AF cells both in vitro and ex vivo. TGF-β1 and collagen 
type I hydrogel-PU scaffold hybrid system retained 
the AF phenotype of implanted cells. These constructs 
have potential for generating tissue engineered AF 
and warrant further investigation for their use in 
repairing AF defects after discectomy.
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Discussion with Reviewers
Cornelia Neidlinger-Wilke: Does the organ culture 
model really simulate in vivo loading conditions? 
The risk of herniation is certainly lower under the 
applied experimental conditions. Could you please 
comment on this?
Authors: In the current study, the IVD organs were 
cultured under physiological axial compressive 
loading condition. This model partially simulated the 
in vivo loading conditions by resulting in a disc height 
loss of ~ 10 % after loading, which is comparable to the 
disc height loss of human lumbar IVD after normal 
daily activity. However, this model does not simulate 
the complex in vivo loading condition, including 
flexion, extension and torsion. In this respect, the 
risk of herniation is certainly lower under the applied 
experimental conditions. Further mechanical test 
under complex loading condition is needed to assess 
the biomechanical compatibility of the implanted 
constructs and fixation method. The current model 
simulated the biological microenvironment of in 
vivo native disc tissue for testing of the implanted 
constructs, representing a good pre-animal model to 
evaluate the biological compatibility of the implanted 
constructs in addition to an in vitro system.
Cornelia Neidlinger-Wilke: Regarding a possible 
in vivo application of such an approach, is this also 
an appropriate solution under the high loaded 
conditions in the physiological disc environment? 
Does the PU membrane sealing also persist under 
complex loading conditions? How can the risk of 
extrusion under high and complex load exposure 
be reduced?
Authors: We agree with the reviewer that many 
more challenges remain to be solved regarding the 
application of this method for AF repair in vivo. In 
the current study, EPIGLU® (Meyer-Haake GmbH) 
was used to stick a membrane for maintaining the 
scaffold in place under a loaded environment. In a 
previous study, a membrane-suture method was used 
to fix the implant (Pirvu et al., 2015). These could all 
be possible options for scaffold fixation. For easier 
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operation-room practice, the cell-seeded scaffold 
could be further developed into an adhesive patch 
to avoid manipulation hassles. 
Fackson Mwale: In the NP, TGF-β1 downregulates 
CCL4 expression through ERK1/2 signalling 
activation (Zhang et al., 2017, additional reference). 
What are the mechanisms underlying the effects of 
TGF-β1 on AF phenotypic induction?
Authors: According to Zhang et al. (2017), TGF-β1 can 
prevent degenerative processes, inhibit inflammatory 
responses in the dorsal root ganglia and prevent 
pain development, by inhibiting CCL4 expression 
via ERK1/2 signalling activation in NP cells. 
However, the mechanism of TGF-β1 on functional 
AF phenotypic induction is yet unclear. Preliminary 
results showed that ERK1/2 inhibitor promoted AF 
functional marker expression independent of TGF-β1 
treatment, which indicated that ERK1/2 signalling 
pathway might also play a role in the regulation of 
AF phenotype markers expression. Ongoing study 
suggests that Smads pathway may play a key role in 
the effects of TGF-β1 on AF phenotypic induction. 
Further experiments are needed to confirm these 
preliminary findings.
Fackson Mwale: Would intradiscal injections of 
TGF-β1 and AF cells be effective?
Authors: Intradiscal injection of TGF-β1 and 
AF cells may be effective for repair of small AF 
ruptures. In case of a large AF defect, an adhesive 
and biocompatible material filler to close the defect 
and restore the mechanical function of the IVD will 
be needed to provide structural support for the 
biological repair.
Fackson Mwale: One of the limitations of the study, 
as pointed out, was the lack of the angle-ply, fibrillar 
organisation of the native AF. Would a 3D-printed 
scaffold in which the layers are printed in opposing 
angular orientations replicating the angle-ply 
arrangement of the native tissue be suitable for the 
collagen PU scaffold used?
Authors: It is a great suggestion to use a 3D-printed 
scaffold to mimic the angle-plied lamellae structure of 
the native AF tissue. Christiani et al. (2019, additional 
reference) developed a tissue engineered AF by 
3D-printed polycaprolactone scaffolds with angle-
plied architecture. It would be also suitable with 
collagen and PU, since both collagen I and PU have 
been widely used for 3D bioprinting. One potential 
direction is to print PU with an angle-plied structure 
as a backbone platform to supply the mechanical 
property and to print another layer of collagen I 
encapsulated with functional cells and bioactive 
agents within the space between the PU layers.
Fackson Mwale: How does this scaffold compare 
with the tensile, compressive and torsional mechanics 
of the AF?
Authors: The unconfined compressive stiffness of 
porous PU scaffold is approximately 20 kPa, which 
is weaker than the native AF tissue (0.19-0.26 MPa) 
(Freeman et al., 2013, additional reference). The 
tensile and torsional mechanical properties of the 
PU scaffold were not measured in the current study. 
Further testing is needed to fully understand the 
mechanical property of the scaffold. The mechanical 
properties of the scaffold may be improved by 
mimicking the angle-plied lamellar microstructure 
of AF instead of random porous architecture. This 
may be achieved by using other technologies, such 
as electrospinning and 3D printing in further studies.
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